Attention-deficit/hyperactivity disorder: Part II. Treatment strategies

Journal of Practical Psychiatry and Behavioral Health

Volumn 2, Issue 1, 1996, Pages 23-32

  March, John S ^a   Wells, Karen ^a   Keith Conners, C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attention deficit hyperactivity disorder; Bupropion; Clonidine; Parent training; Psychostimulant medications; Treatment; Tricyclic antidepressants

Indexed keywords

EID: 33751282242     PISSN: 10765417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Safer D, Krager JM. Hyperactivity and inattentiveness: School assessment of stimulant treatment. Clin Pediatr 1989;28(5):216-21.
2. Greenhill LL. Pharmacologie treatment of attention deficit hyperactivity disorder. [Review]. Psychiatr Clin North Am 1992;15:l-27.
3. March J, Gönners C, Erhardt D, Johnston H. Pharmacotherapy of attention-deficit hyperactivity disorder. In: Jefferson J, Greist J, eds. Psychiatric Clinics of North America: Annual of drug therapy. Vol 2. Philadelphia: Saunders; 1995:187-213.
4. Wilens T, Biederman J. The stimulants. In: Shaffer D, ed. Psychiatric Clinics of North America: Pédiatrie psychopharmacology. Vol 15. Philadelphia: Saunders; 1992:191-222.
5. Green W. Non-stimulant drugs in the treatment of attention-deficit hyperactivity disorder. In: Shaffer D, ed. Child Psychiatric Clinics of North America: Attention-deficit hyperactivity disorder. Vol 15. Philadelphia: Saunders; 1992:449-65.
6. Wells K. Adaptations for specific populations. In: McMahon R, Forehand R, eds. Helping the non-compliant child: A clinician's guide to parent training. New York: Guilford. In press.
7. Conners C, Wells K, March J, Fiore C. Methodological issues in the multimodal treatment of the disruptive behavior disorders. In: Greenhill L, ed. Psychiatric Clinics of North America: Disruptive behavior disorders. Philadelphia: Saunders; 1994:361-78.
8. Shaffer D. Attention deficit hyperactivity disorder in adults. Am J Psychiatry 1994;151(5):633-8.
9. Wender PH. Attention-deficit hyperactivity disorder in adults. London: Oxford University Press; 1995.
10. Bradley W. The behavior of children receiving Benzedrine. Am J Psychiatry 1937;94:577-85
11. Swanson J. Effect of stimulant medication on hyperactive children: A review of reviews. Exceptional Child 1993;60:154-62.
12. Maletic V, March J, Johnston H. Child and adolescent psychopharmacology. In: Jefferson J, Greist J, eds. Psychiatric Clinics of North America: Annual of drug therapy. Philadelphia, PA: Saunders; 1994:101-24.
13. Erhardt D, Conners C. Methodological and assessment issues in pedi atric psychopharmacology. In: Wiener J, ed. Diagnosis and psychopharmacology of childhood and adolescent disorders. New York: Wiley;in press.
14. Rapport M. Controlled studies of the effects of psychostimulants on children's functioning in clinic and classroom settings. In: Conners C, Kinsbourne M, eds. ADHD: Attention deficit hyperactivity disorder. Munich: MMV Medzin Verlag Munche; 1991.
15. Mannuzza S, Klein RG, Addalli KA. Young adult mental status of hyperactive boys and their brothers: A prospective follow-up study. J. Am Acad Child Adolesc Psychiatry 1991;30(5):743-51.
16. Klein RG, Mannuzza S. Long-term outcome of hyperactive children: A review. J Am Acad Child Adolesc Psychiatry 1991;30(3):383-7.
17. Satterfield J, Cantwell D, Satteriield B. Multimodality treatment: A one-year follow-up of 84 hyperactive boys. Arch Gen Psychiatry 1979;36,955-4.
18. Satterfield J, Satteriield B, Schell A. Therapeutic interventions to prevent delinquency in hyperactive boys. J Am Acad Child Adolesc Psychiatry 1987;26:56-64.
19. Biederman J, Baldessarini RJ, Wright V, et al. A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. J Am Acad Child Adolesc Psychiatry 1989a;28:777-S4.
20. Biederman J, Baldessarini RJ, Wright V, et al. A double-blind placebo controlled study of desipramine in the treatment of ADD: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 1989b; 28:903-11.
21. Wilens TE, Biederman J, Geist DE, et al: Nortriptyline in the treatment of ADHD: A chart review of 58 cases. J Am Acad Child Adolesc Psychiatry 1993;32:343-9.
22. Elliott G, Popper C. Tricyclic antidepressants: The QT interval and other cardiovascular parameters. J Child and Adolesc Psychopharmacology 1991;1:187-91.
23. Casat C, Pleasants D, Schroeder D. Bupropion in children with attention-deficit hyperactivity disorder. Psychopharmacol Bull 1989; 25:198-201.
24. Clay T, Gualtieri C, Evants R. Clinical and neuropsychological effects of the novel antidepressant bupropion. Psychopharmacol Bull 1988; 24:143-S
25. Simeon JG, Ferguson HB, Van WFJ: Bupropion effects in attention deficit and conduct disorders. Special Issue: Canadian Academy of Child Psychiatry: A Canadian perspective. Can J Psychiatry 1986;31:581-5.
26. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry 1985;24:617-29.
27. Cohen DJ, Riddle MA, Leckman JF. Pharmacotherapy of Tourette's syndrome and associated disorders.[review] Psychiatr Clin North Am 1992;15:109-29
28. Steingard R, Biederman J, Spencer T, et al. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 1993; 32:350-3
29. Spencer T, Wilens T, Biederman J, Faraone S, Ablon S. A double-blind crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Paper presented at the NCDEU, Marco Island, FL, 1994
30. Pelham W, Greenslade K, Vodde-Hamilton M, Murphy D. Relative efficacy of long-acting stimulants in children with attention deficit hyperactivity disorder. A comparison of standard methylphenidate, sustained release methylphenidate, sustained release dextroamphetamine, and pemoline. Pediatrics 1990;86:226-37.
31. Elia J, Borcherding B, Rapoport J, Keysor C. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Research 1991;36:141-55.
32. Carlson G. Identifying prepubertal mania. J Am Acad Child Adolesc Psychiatry 1995; 34(6):750-3.
33. Pelham WE, Hoza B. Comprehensive treatment for ADHD: Intensive summer treatment programs and follow-up. In: Hibbs ED, Jensen PS, eds. Psychosocial treatment research of child and adolescent disorders. Washington, DC: American Psychiatric Press; in press.
34. Wells KG. What do we know about the use and effects of behavior therapies in the treatment of ADD? Journal of Children in Contemporary Society 1986;19:lll-22.
35. Pfifiher L, Barkley R. Educational placement and classroom management. In: Barkley R, ed. Attention deficit hyperactivity disorder. New York: Guilford Press; 1990:498-539.
36. Abikoff H. Cognitive training in ADHD children: Less to it than meets the eye. Journal of Learning Disabilities 1991;24:205-9.
37. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991;148:564-77
38. Hinshaw S. Stimulant medication and the treatment of aggression in children with attentional deficits. Journal of Clinical Child Psychology 1991;20:301-12
39. Gadow K, Sverd J. Stimulants for ADHD in child patients with Tourette's syndrome: The issue of relative risk. Developmental and Behavioral Pediatrics 1990;11(5): 269-71.
40. Pennington B. Right hemisphere learning disorders. In: Pennington B, ed. Diagnosing learning disorders. New York: Guilford Press; 1991:111-34.